These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Withdrawal of oxyphenbutazone: what about phenylbutazone? Biron P CMAJ; 1986 May; 134(10):1119-20. PubMed ID: 3697857 [No Abstract] [Full Text] [Related]
14. Fixed drug eruption to oxyphenbutazone and phenylbutazone. Nayyar KC; Pasricha JS Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722 [No Abstract] [Full Text] [Related]
15. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
16. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
17. Fixed eruption due to two unrelated drugs: oxyphenbutazone and tetracycline. Bhargava NC; Singh G Int J Dermatol; 1981; 20(6):435. PubMed ID: 6455387 [No Abstract] [Full Text] [Related]
18. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone. Sperling IL Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850 [No Abstract] [Full Text] [Related]
19. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
20. Phenylbutazone and oxyphenbutazone: time to call a halt. Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755 [No Abstract] [Full Text] [Related] [Next] [New Search]